IBRX logo

ImmunityBio (IBRX) Working capital

annual working capital:

$129.64M-$106.16M(-45.02%)
December 31, 2024

Summary

  • As of today (June 29, 2025), IBRX annual working capital is $129.64 million, with the most recent change of -$106.16 million (-45.02%) on December 31, 2024.
  • During the last 3 years, IBRX annual working capital has risen by +$164.29 million (+474.17%).
  • IBRX annual working capital is now -45.02% below its all-time high of $235.80 million, reached on December 31, 2023.

Performance

IBRX Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIBRXbalance sheet metrics

quarterly working capital:

$59.96M-$69.68M(-53.75%)
March 31, 2025

Summary

  • As of today (June 29, 2025), IBRX quarterly working capital is $59.96 million, with the most recent change of -$69.68 million (-53.75%) on March 31, 2025.
  • Over the past year, IBRX quarterly working capital has dropped by -$82.00 million (-57.77%).
  • IBRX quarterly working capital is now -74.57% below its all-time high of $235.80 million, reached on December 31, 2023.

Performance

IBRX quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIBRXbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

IBRX Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-45.0%-57.8%
3 y3 years+474.2%+135.6%
5 y5 years--

IBRX Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-45.0%+136.0%-74.6%+111.0%
5 y5-year-45.0%+136.0%-74.6%+111.0%
alltimeall time-45.0%+136.0%-74.6%+111.0%

IBRX Working capital History

DateAnnualQuarterly
Mar 2025
-
$59.96M(-53.8%)
Dec 2024
$129.64M(-45.0%)
$129.64M(+26.9%)
Sep 2024
-
$102.19M(-43.5%)
Jun 2024
-
$180.72M(+27.3%)
Mar 2024
-
$141.96M(-39.8%)
Dec 2023
$235.80M(-165.4%)
$235.80M(+89.0%)
Sep 2023
-
$124.76M(-122.8%)
Jun 2023
-
-$546.65M(+21.1%)
Mar 2023
-
-$451.46M(+25.3%)
DateAnnualQuarterly
Dec 2022
-$360.28M(+939.8%)
-$360.28M(-598.6%)
Sep 2022
-
$72.25M(-127.7%)
Jun 2022
-
-$261.06M(+54.8%)
Mar 2022
-
-$168.67M(+386.8%)
Dec 2021
-$34.65M(-179.5%)
-$34.65M(-219.3%)
Sep 2021
-
$29.04M(-26.1%)
Jun 2021
-
$39.30M(+99.4%)
Mar 2021
-
$19.71M(-54.8%)
Dec 2020
$43.58M
$43.58M

FAQ

  • What is ImmunityBio annual working capital?
  • What is the all time high annual working capital for ImmunityBio?
  • What is ImmunityBio annual working capital year-on-year change?
  • What is ImmunityBio quarterly working capital?
  • What is the all time high quarterly working capital for ImmunityBio?
  • What is ImmunityBio quarterly working capital year-on-year change?

What is ImmunityBio annual working capital?

The current annual working capital of IBRX is $129.64M

What is the all time high annual working capital for ImmunityBio?

ImmunityBio all-time high annual working capital is $235.80M

What is ImmunityBio annual working capital year-on-year change?

Over the past year, IBRX annual working capital has changed by -$106.16M (-45.02%)

What is ImmunityBio quarterly working capital?

The current quarterly working capital of IBRX is $59.96M

What is the all time high quarterly working capital for ImmunityBio?

ImmunityBio all-time high quarterly working capital is $235.80M

What is ImmunityBio quarterly working capital year-on-year change?

Over the past year, IBRX quarterly working capital has changed by -$82.00M (-57.77%)
On this page